company-logo

Asarina Pharma AB (publ), a biotech company, researches and develops pharmaceutical products. Its flagship product is Sepranolone, which is used for the treatment of menstrual migraine and Tourette syndrome. The company was formerly known as Umecrine Mood AB and changed its name to Asarina Pharma AB (publ) in 2016. Asarina Pharma AB (publ) was incorporated in 2005 and is based in Solna, Sweden.

Asarina Pharma Dividend Announcement

Asarina Pharma does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
Stay tuned for updates on Asarina Pharma dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Asarina Pharma Dividend History

Asarina Pharma Dividend Yield

Asarina Pharma current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Asarina Pharma stock? Use our calculator to estimate your expected dividend yield:

Asarina Pharma Financial Ratios

P/E ratio-0.08
PEG ratio-0.00
P/B ratio0.38
ROE-278.02%
Payout ratio0.00%
Current ratio1.20
Quick ratio1.20
Cash Ratio0.71

Asarina Pharma Dividend FAQ

Does Asarina Pharma stock pay dividends?
Asarina Pharma does not currently pay dividends to its shareholders.
Has Asarina Pharma ever paid a dividend?
No, Asarina Pharma has no a history of paying dividends to its shareholders. Asarina Pharma is not known for its dividend payments.
Why doesn't Asarina Pharma pay dividends?
There are several potential reasons why Asarina Pharma would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Asarina Pharma ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Asarina Pharma has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Asarina Pharma a dividend aristocrat?
Asarina Pharma is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Asarina Pharma a dividend king?
Asarina Pharma is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Asarina Pharma a dividend stock?
No, Asarina Pharma is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Asarina Pharma stocks?
To buy Asarina Pharma you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Asarina Pharma stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.